Landec's Q4 and Full Year Earnings Estimates Lowered
12:26AM ET 7/05/2019 MT NewswiresThe Q4 and 2019 forecasted earnings estimates for Landec Corp's (NASDAQ:LNDC, Recent Price: 9.99) for the quarter ending May 31, 2019 and year ending May...
Quotes Snapshot > LNDC
Landec Corp LNDC:NASDAQ
Last Price$10.57NASDAQ Closing Price as of 4:00PM ET 7/15/19
NASDAQ 15-minute delayed Bid/Ask Quotes
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change+0.06(0.57%)
Bid (Size)$10.56 (4)
Ask (Size)$10.57 (7)
Day Low / High$10.37 - 10.59
Volume84.6 K
Read more news Recent News
Analysts Target Lower Outlook for Landec's Q4 and Full Year Earnings
12:26AM ET 7/04/2019 MT NewswiresThe May 31, 2019 quarterly, and May 31, 2019 full year earnings estimates for Landec Corp (NASDAQ:LNDC, Recent Price: 9.99) have been lowered. The...
Landec to Strealine Products to Cut Costs, Sees Charges of $0.13/Share in Q4
4:24PM ET 7/01/2019 MT NewswiresLandec (LNDC) said on Monday it plans to simplify its Curation Foods business to cut costs, which would result in an after-tax charge of $3.8 million, or...
Insider Trends: Landec Insider Converts Option/Derivative Security Sells Portion to Pay Tax, Buy Trend Intact
9:14PM ET 5/28/2019 MT NewswiresMolly Hemmeter, CEO, exercised options/derivative securities for 71,574 shares of Landec (LNDC) and sold 24,815 shares in the company for $232,020 to meet...
View all Commentary and Analysis
Landec: Buy, Sell Or Hold?
3:13PM ET 5/14/2019 Seeking AlphaInsider Weekends: Richard Kinder Adds To His Stake In Kinder Morgan
1:14AM ET 4/15/2019 Seeking AlphaDaily Insider Ratings Roundup 4/11/19
6:37PM ET 4/12/2019 Seeking AlphaDaily Insider Ratings Round Up 4/10/19
6:39AM ET 4/12/2019 Seeking AlphaCompany Profile
Business DescriptionLandec Corp. engages in the design, development, manufacture and sale of health and wellness products for food and biomaterials markets. It operates through the following segments: Packaged Fresh Vegetables, Biomaterials, and Other. The Packaged Fresh Vegetables segment markets and packs specialty packaged whole, and fresh-cut fruit and vegetables. The Biomaterials segment sells products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans, and non-HA products for medical use primarily in the Ophthalmic, Orthopedic, and other markets. The Other segment includes corporate general and administrative expenses, non-packaged fresh vegetables, and non-biomaterials interest income and income tax expenses. The company was founded by Ray Stewart on October 31, 1986 and is headquartered in Santa Clara, CA. View company web site for more details
| Address | 5201 Great America Parkway Santa Clara, California 95054 |
| Phone | +1.650.306.1650 |
| Number of Employees | 710 |
| Recent SEC Filing | 07/03/2019 8-K |
| President, Chief Executive Officer & Director | Albert D. Bolles |
| CFO, Executive VP-Finance & Administration | Gregory S. Skinner |
| Vice President-Technology | Steven P. Bitler |
| Vice President | James G. Hall |
Company Highlights
| Price Open | $10.49 |
| Previous Close | $10.51 |
| 52 Week Range | $9.02 - 15.57 |
| Market Capitalization | $308.5 M |
| Shares Outstanding | 29.2 M |
| Sector | Process Industries |
| Industry | Industrial Specialties | Next Earnings Announcement | 07/30/2019 |
Options Summary
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
View all fundamentalsFundamentals
| Price / Earnings | 42.04 |
| Earnings per Share | $0.14 |
| Beta vs. S&P 500 | N/A |
| Revenue | $524.2 M |
| Net Profit Margin | 1.35% |
| Return on Equity | 2.87% |
Analyst Ratings as of 07/05/2019
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |